Semin Respir Crit Care Med 2008; 29(6): 680-684
DOI: 10.1055/s-0028-1101278
© Thieme Medical Publishers

The Future of Occupationally Related Diffuse Lung Disease

Amy M. Nuernberg1 , 2 , David C. Christiani1 , 2
  • 1Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts
  • 2Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Further Information

Publication History

Publication Date:
16 February 2009 (online)

ABSTRACT

In the last 10 years alone, several new occupational lung diseases have been described. Progress in improving measurements of exposures and risk factors for exposure-related diseases has turned to molecular epidemiology and genomics methods in recent years. There has been a dramatic increase in the number of studies investigating genetic associations and biomarkers in occupationally related diffuse lung diseases. Specifically, identifying common variant genetic polymorphisms that may have low penetrance (modest relative risk), but impart a high population-attributable risk of disease when exposure occurs, has been a recent research focus. Candidate gene methodology is currently the most popular approach, but genome-wide association studies are now more feasible for studying gene–environment interactions. The results of these studies will better define populations at particularly high risk of disease after exposure, but it is important to realize that the mainstay of prevention for occupationally related diffuse lung disease remains prevention and control of airborne exposures.

REFERENCES

  • 1 Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes E J, Enright P L. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant.  N Engl J Med. 2002;  347 330-338
  • 2 Kern D G, Crausman R S, Durand K TH, Nayer A, Kuhn C. Flock workers's lung: chronic interstitial lung disease in the nylon flocking industry.  Ann Intern Med. 1998;  129 261-272
  • 3 Centers for Disease Control and Prevention (CDC) . Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria—Ohio, 2001.  MMWR Morb Mortal Wkly Rep. 2002;  51 349-352
  • 4 Izbicki G, Chavko R, Banauch G I et al.. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers.  Chest. 2007;  131 1414-1423
  • 5 Ramos R G, Olden K. Gene–environment interactions in the development of complex disease phenotypes.  Int J Environ Res Public Health. 2008;  5 4-11
  • 6 Kleeberger S R, Ohtsuka Y. Gene–particulate matter–health interactions.  Toxicol Appl Pharmacol. 2005;  207(Suppl 2) S276-S281
  • 7 Ordovas J M, Tai E S. Why study gene–environment interactions?.  Curr Opin Lipidol. 2008;  19 158-167
  • 8 Le Marchand L, Wilkens L R. Design considerations for genomic association studies: importance of gene–environment interactions.  Cancer Epidemiol Biomarkers Prev. 2008;  17 263-267
  • 9 Wang Z, Neuburg D, Li C et al.. Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes.  Environ Health Perspect. 2005;  113 233-241
  • 10 Kim J Y, Hecht S S, Mukherjee S, Carmella S G, Rodrigues E G, Christiani D C. A urinary metabolite of phenanthrene as a biomarkers of polycyclic aromatic hydrocarbon metabolic activation in workers exposed to residual oil fly ash.  Cancer Epidemiol Biomarkers Prev. 2005;  14 687-692
  • 11 Kim J Y, Mukherjee S, Ngo L, Christiani D C. Urinary 8-hydroxy-2'-deoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to fine particulates.  Environ Health Perspect. 2004;  112 666-671
  • 12 Nuernberg A M, Boyce P D, Cavallari J M, Fang S C, Eisen E A, Christiani D C. Urinary 8-isoprostane and 8-OHdG concentrations in boilermakers with welding exposure.  J Occup Environ Med. 2008;  50 182-189
  • 13 National Research Council, Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology .Report in Brief: Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment. Washington, DC; National Academies Press 2007 Available at: http://dels.nas.edu/dels/rpt_briefs/toxicogenomic_technologies_final.pdf. Accessed July 12, 2008
  • 14 Schmidt C W. Toxicogenomics: an emerging discipline.  Environ Health Perspect. 2002;  110 A750-A755
  • 15 Weinhold B. Epigenetics: the science of change.  Environ Health Perspect. 2006;  114 A160-A167
  • 16 The Human Epigenome Project .Project description. Available at: http://www.epigenome.org/index.php?page=project Accessed July 25, 2008
  • 17 Seo T, Pahwa P, McDuffie H H et al.. Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers.  Pharmacogenet Genomics. 2008;  18 487-493
  • 18 Lympany P A, du Bois R M. Diffuse lung disease: product of genetic susceptibility and environmental encounters.  Thorax. 1997;  52 92-94
  • 19 Saltini C, Amicosante M, Franchi A, Lombardi G, Richeldi L. Immunogenetic basis of environmental lung disease: lessons from the berylliosis model.  Eur Respir J. 1998;  12 1463-1475
  • 20 Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.  Science. 1993;  262 242-244
  • 21 Christiani D C, Mehta A J, Yu C-L. Genetic susceptibility to occupational exposures.  Occup Environ Med. 2008;  65 430-436
  • 22 Kleeberger S R, Peden D. Gene–environment interactions in asthma and other respiratory diseases.  Annu Rev Med. 2005;  56 383-400
  • 23 Nadif R, Mintz M, Jedlicka A, Kauffmann F, Kleeberger S R. IL18 and IL18R1 polymorphisms, lung CT and fibrosis: a longitudinal study in coal miners.  Eur Respir J. 2006;  28 1100-1105
  • 24 Nadif R, Mintz M, Rivas-Fuentes S et al.. Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis.  Cytokine. 2006;  33 171-178
  • 25 National Office of Public Health Genomics .Public Health Genomics at CDC: Accomplishments and Priorities 2004, National Institute of Occupational Safety and Health Report. Atlanta, GA; Centers for Disease Control and Prevention 2004 Available at: http://www.cdc.gov/genomics/activities/file/print/2004report/NIOSH_2004.pdf Accessed July 22, 2008
  • 26 The Environmental Genome Project .Program description. Available at: http://www.niehs.nih.gov/research/supported/programs/egp/ Accessed July 22, 2008
  • 27 National Research Council, Committee to Review the NIOSH Respiratory Disease Research Program .Respiratory Disease Research at NIOSH: Reviews of Research Programs from the National Institute for Occupational Safety and Health. Washington, DC; National Academies Press 2008 122-125 Available at: http://www.nap.edu/catalog.php?record_id=12171 Accessed July 28, 2008
  • 28 The Exposure Biology Program .Program description. Available at: http://www.gei.nih.gov/exposurebiology/ Accessed July 22, 2008

David C ChristianiM.D. M.P.H. M.S. 

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital

665 Huntington Ave., SPH I-1407, Boston, MA 02115

Email: dchris@hsph.harvard.edu